• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TNF and LDL receptor on brain tumor cultured cells and antitumor activity of TNF

Research Project

Project/Area Number 62480310
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Cerebral neurosurgery
Research InstitutionMedical College of OITA

Principal Investigator

MORI Teruaki  Medical College of OITA. Associate professor, 医学部, 助教授 (60124632)

Co-Investigator(Kenkyū-buntansha) SUGIYAMA Satoru  Medical College of OITA. Lecturer, 医学部, 講師 (50154498)
Project Period (FY) 1987 – 1988
Project Status Completed (Fiscal Year 1988)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 1988: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1987: ¥2,700,000 (Direct Cost: ¥2,700,000)
KeywordsTNF receptor / LDL receptor / Brain tumor / Antitumor activity / Nude mouse / 臨床治験 / TNF / 脳腫瘍 / TNF薬物動態 / brain tumor / TNFreceptor / LDLreceptor
Research Abstract

Purpose: We were examined TNF and LDL receptor on brain tumor cultured cells and antitumor activity of TNF in a experimental and clinical study. Method: In vitor study:
1. TNF and LDL receptor on three glioma cell lines were examined with ^<125>I-TNF and LDL binding assay.
2. Four glioma cell lines were exposed to 100 or1000u/ml of rrecombinant human TNF (PT-050, supplied by Dainippon Pharmaceutical Co., Ltd.) and examined for cytostatic activity and cell cycle. In vivo study:
3. Two human glioma cell lines and a rat glioma transplanted in nude mice were treated with 10,000U/0.05ml of TNF given intravenously or intratumorally 7 times daily. Subsequentry the tumors were measured and examined histologically.
4. Four dog normal brains were examined histologically after TNF intracarotidarterial (ia.)injection. In clinical study:
5. Eight cases with malignant brain tumor were treated with TNF 25-300 x10^4U/body iv. twice/week. Effect of therapy was evaluated by tumor size on CT.
6. TNF concentration in CSF and tumor tissue ofa glioblastoma was measured after TNF injection intravenously. Results:1. TNF receptors were abundant in human glioma cells and little in rat glioma cells LDL receptors were confirmed in two rat glioma cells. 2. TNF had a cytostatic effect on rat glioma cells. TNF accumlated G2+M and/ or S phase cells. 3. Human gliomas transplanted into nude mice were highly sensitive to TNF compared with rat glioma. the tumor reduction was most remarkable in the intratumoral imjection group. pathological changes were mainly due to the obstructive effect of TNF on tumor blood vessels. 4. No abnormal finding couldbe seen in the brains of dogs pathologicaly after TNF ia. injection. 5. Partial remission could be seen in two cases. side effects were hypotention , fever and liver dysfunction. but they were not so severe. 6. TNF could be detected in tumor tissue only after ia.injection.

Report

(3 results)
  • 1988 Annual Research Report   Final Research Report Summary
  • 1987 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] 森照明: Neurologia medico-chirurgica. 29. (1989)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Mori,Teruaki: "TNF and LDL receptor on brain tumor cultured cells and antitumor activity of TNF" Japanese Journal of Cancer and Chemotherapy. (1989)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Mori,Teruaki: "TNF therapy of malignant brain tumor" Neurologia Medico-Chirurgica. (1989)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] 森照明: Neurologia-medico-chirurgica. 29. (1989)

    • Related Report
      1988 Annual Research Report
  • [Publications] 森照明: 神経外科. 23. (1988)

    • Related Report
      1987 Annual Research Report

URL: 

Published: 1987-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi